Cantargia reports first non-squamous NSCLC patient treated with nadunolimab, Keytruda® and chemotherapy

(Nasdaq: CANTA) (Stockholm: CANTA) today reported that the first patient has been treated in a new arm of...

Related Keywords

Sweden ,Stockholm ,Prnewswire Cantargia , ,Nasdaq Stockholm ,